Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism-Reference-Cited by-同舟云学术

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

Published:2010-09-19 Issue:10 Volume:13 Page:1265-1270
ISSN:1097-6256
Container-title:Nature Neuroscience
language:en
Short-container-title:Nat Neurosci

Author:

Clapper Jason R,Moreno-Sanz Guillermo,Russo Roberto,Guijarro Ana,Vacondio Federica,Duranti Andrea,Tontini Andrea,Sanchini Silvano,Sciolino Natale R,Spradley Jessica M,Hohmann Andrea G,Calignano Antonio,Mor Marco,Tarzia Giorgio,Piomelli Daniele

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

http://www.nature.com/articles/nn.2632.pdf

Reference42 articles.

1. Stein, C., Schafer, M. & Machelska, H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 9, 1003–1008 (2003).

2. Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature 394, 277–281 (1998).

3. Nackley, A.G., Suplita, R.L. II & Hohmann, A.G. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 117, 659–670 (2003).

4. Dziadulewicz, E.K. et al. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. J. Med. Chem. 50, 3851–3856 (2007).

5. Anand, P., Whiteside, G., Fowler, C.J. & Hohmann, A.G. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res. Rev. 60, 255–266 (2009).

Cited by 289 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level;Physiological Research;2024-08-31

2. ART26.12, a novel fatty acid‐binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models;European Journal of Pain;2024-08-26

3. Serum levels of hydroxylated metabolites of arachidonic acid cross-sectionally and longitudinally predict knee pain progression: an observational cohort study;Osteoarthritis and Cartilage;2024-08

4. Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology;Psychiatry Research;2024-07

5. Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy;The Journal of Pain;2024-07